Quest Diagnostics Incorporated Stock Price Prediction
| DGX Stock | USD 175.41 1.35 0.78% |
Momentum 64
Buy Extended
Oversold | Overbought |
Using Quest Diagnostics hype-based prediction, you can estimate the value of Quest Diagnostics Incorporated from the perspective of Quest Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Quest Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Quest because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Quest Diagnostics after-hype prediction price | USD 175.41 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Quest |
Quest Diagnostics After-Hype Price Prediction Density Analysis
As far as predicting the price of Quest Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Quest Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Quest Diagnostics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Quest Diagnostics Estimiated After-Hype Price Volatility
In the context of predicting Quest Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Quest Diagnostics' historical news coverage. Quest Diagnostics' after-hype downside and upside margins for the prediction period are 174.08 and 176.74, respectively. We have considered Quest Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Quest Diagnostics is very steady at this time. Analysis and calculation of next after-hype price of Quest Diagnostics is based on 3 months time horizon.
Quest Diagnostics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Quest Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Quest Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Quest Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 1.33 | 0.00 | 0.04 | 0 Events / Month | 5 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
175.41 | 175.41 | 0.00 |
|
Quest Diagnostics Hype Timeline
On the 25th of February Quest Diagnostics is traded for 175.41. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.04. Quest is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.14%. %. The volatility of related hype on Quest Diagnostics is about 424.92%, with the expected price after the next announcement by competition of 175.37. About 93.0% of the company shares are held by institutions such as insurance companies. The book value of Quest Diagnostics was currently reported as 61.06. The company has Price/Earnings To Growth (PEG) ratio of 1.41. Quest Diagnostics recorded earning per share (EPS) of 7.68. The entity last dividend was issued on the 7th of April 2025. The firm had 2:1 split on the 21st of June 2005. Considering the 90-day investment horizon the next forecasted press release will be in a few days. Check out Quest Diagnostics Basic Forecasting Models to cross-verify your projections.Quest Diagnostics Related Hype Analysis
Having access to credible news sources related to Quest Diagnostics' direct competition is more important than ever and may enhance your ability to predict Quest Diagnostics' future price movements. Getting to know how Quest Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Quest Diagnostics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IQV | IQVIA Holdings | (4.82) | 9 per month | 1.37 | (0) | 2.20 | (2.63) | 7.16 | |
| MTD | Mettler Toledo International | 0.00 | 0 per month | 1.23 | 0.06 | 2.34 | (2.60) | 8.21 | |
| TWST | Twist Bioscience Corp | (1.41) | 11 per month | 3.54 | 0.01 | 6.08 | (6.04) | 18.27 | |
| WAT | Waters | (1.93) | 3 per month | 1.55 | 0.06 | 3.00 | (2.56) | 10.90 | |
| ICLR | ICON PLC | 3.59 | 6 per month | 1.83 | 0.04 | 4.13 | (2.13) | 12.62 | |
| IDXX | IDEXX Laboratories | (1.35) | 9 per month | 1.47 | 0.07 | 2.72 | (2.63) | 14.45 | |
| CRL | Charles River Laboratories | 0.00 | 0 per month | 0.00 | (0.13) | 4.59 | (3.92) | 11.52 | |
| RVTY | Revvity | 0.00 | 0 per month | 1.52 | (0) | 3.29 | (2.62) | 11.13 | |
| SHC | Sotera Health Co | 0.23 | 9 per month | 0.00 | (0.01) | 2.54 | (2.63) | 6.91 | |
| A | Agilent Technologies | 2.56 | 7 per month | 1.03 | 0.06 | 2.81 | (1.91) | 6.12 |
Quest Diagnostics Additional Predictive Modules
Most predictive techniques to examine Quest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Quest using various technical indicators. When you analyze Quest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Quest Diagnostics Predictive Indicators
The successful prediction of Quest Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Quest Diagnostics Incorporated, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Quest Diagnostics based on analysis of Quest Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Quest Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Quest Diagnostics's related companies.
Story Coverage note for Quest Diagnostics
The number of cover stories for Quest Diagnostics depends on current market conditions and Quest Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Quest Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Quest Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Quest Diagnostics Short Properties
Quest Diagnostics' future price predictability will typically decrease when Quest Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Quest Diagnostics Incorporated often depends not only on the future outlook of the potential Quest Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quest Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 113 M | |
| Cash And Short Term Investments | 549 M |
Additional Tools for Quest Stock Analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.